Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Lantheus (LNTH)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX – Research Report) and Lantheus (LNTH – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Argenx Se (ARGX)
In a report released today, Alex Thompson CFA from Stifel Nicolaus reiterated a Buy rating on Argenx Se, with a price target of $1227.00. The company’s shares closed last Thursday at $772.18.
According to TipRanks.com, CFA is a 5-star analyst with an average return of
Argenx Se has an analyst consensus of Strong Buy, with a price target consensus of $1048.14, implying a 30.8% upside from current levels. In a report issued on February 19, Jefferies also maintained a Buy rating on the stock with a $1008.00 price target.
See the top stocks recommended by analysts >>
Lantheus (LNTH)
Lantheus received a Buy rating from William Blair analyst Andy Hsieh today. The company’s shares closed last Thursday at $77.61.
According to TipRanks.com, Hsieh is a 4-star analyst with an average return of
Currently, the analyst consensus on Lantheus is a Strong Buy with an average price target of $76.75, representing a 1.4% upside. In a report issued on February 24, Citizens JMP also maintained a Buy rating on the stock with a $78.00 price target.
